AbbVie Gets Another Ulcerative Colitis Contender via $137M Landos Acquisition
AbbVie already has blockbuster medicine for ulcerative colitis, however that isn’t stopping the pharmaceutical big from making an attempt ...
AbbVie already has blockbuster medicine for ulcerative colitis, however that isn’t stopping the pharmaceutical big from making an attempt ...
AbbVie’s portfolio and pipeline is skinny on mind medication, significantly within the space of neurodegeneration. The pharmaceutical large ...
AbbVie’s blockbuster large, Humira, is used to being high canine within the pharma trade. But it surely had a ...
Ahead of its state-of-the-company address at the J.P. Morgan Health Care Conference, AbbVie took the uncommon action of reconfirming ...
AbbVie is taking a various tack in its battle with Alvotech over the Icelandic business's Humira biosimilar program, this ...
With the FDA's JAK doubts enduring, atopic dermatitis hopefuls from AbbVie and Eli Lilly will need to keep waiting ...
As drug rates chatter gains steam when again in Washington, D.C., pharma business have actually been silently raising costs ...
AbbVie has actually tattooed a series of patent settlements with biosimilar makers enabling U.S. copycat launches to the world's ...
As AbbVie prepare for its post-Humira future, its immunology drugs Rinvoq and Skyrizi are bring huge expectations. Nevertheless, the ...
AbbVie's most recent profits streams come thanks to Evolus and its Botox rival Jeuveau. To settle a long-running legal ...
Copyright © 2021 Infiniti CS News
Copyright © 2021 Infiniti CS News